Tetravalent influenza split virion vaccine, inactivated (Hualan Biological Vaccines)

四价流感病毒裂解疫苗（华兰生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTetravalent influenza split virion vaccine, inactivated (Hualan Biological Vaccines)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2018/06/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Ankang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Ankang Biotechnology Co Ltd
Inactive CompaniesHualan Biological Bacterin Co Ltd
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A